Achieve Life Sciences, Inc.ACHVNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P28
Within normal range
vs 2Y Ago
-1.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -24.94% |
| Q2 2025 | 18.21% |
| Q1 2025 | -20.67% |
| Q4 2024 | 11.41% |
| Q3 2024 | -110.77% |
| Q2 2024 | 6.94% |
| Q1 2024 | -21.17% |
| Q4 2023 | 15.03% |
| Q3 2023 | 23.07% |
| Q2 2023 | 19.60% |
| Q1 2023 | 25.49% |
| Q4 2022 | 1.45% |
| Q3 2022 | -35.90% |
| Q2 2022 | -22.73% |
| Q1 2022 | -29.92% |
| Q4 2021 | 39.98% |
| Q3 2021 | 4.21% |
| Q2 2021 | -40.67% |
| Q1 2021 | -160.16% |
| Q4 2020 | 42.79% |
| Q3 2020 | -97.22% |
| Q2 2020 | 50.73% |
| Q1 2020 | -30.67% |
| Q4 2019 | -11.13% |
| Q3 2019 | 20.02% |
| Q2 2019 | 21.44% |
| Q1 2019 | -38.07% |
| Q4 2018 | -18.79% |
| Q3 2018 | -59.58% |
| Q2 2018 | 16.35% |
| Q1 2018 | 38.37% |
| Q4 2017 | -159.96% |
| Q3 2017 | 338.72% |
| Q2 2017 | 71.86% |
| Q1 2017 | -28.89% |
| Q4 2016 | 3.91% |
| Q3 2016 | -14.31% |
| Q2 2016 | 30.08% |
| Q1 2016 | 14.96% |
| Q4 2015 | -23.78% |